This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_NSCLC_ADENO_EXALLC for full statistics.
Non-small cell lung cancer, adenocarcinoma
C3_NSCLC_ADENO
non-small cell lung carcinoma: A group of at least three distinct histological types of lung cancer, including non-small cell squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Non-small cell lung carcinomas have a poor response to conventional chemotherapy.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
2303 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2303 |
4. Check minimum number of eventsNone |
2303 |
5. Include endpoints |
2303 |
6. Filter based on genotype QC (FinnGen only) |
2303 |
Control definitions (FinnGen only)
- Control conditions
- not HLP_C3_NSCLC_ADENO
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Non-small cell lung cancer, adenocarcinoma
based on the number of shared cases.
Similar with more cases:
- Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)
- Non-small cell lung cancer, adenocarcinoma, helper endpoint
- Non-small cell lung cancer
- Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of bronchus and lung
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2303 | 887 | 1416 |
| Unadjusted period prevalence (%) | 0.50 | 0.30 | 0.62 |
| Median age at first event (years) | 70.34 | 69.06 | 71.15 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2148
- Matched controls
- 21478
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
9.8
323.0
814
1255
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
133.8
323.0
446
42
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
31.5
323.0
710
331
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
63.1
323.0
493
101
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
323.0
831
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
12.0
323.0
861
1130
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
11257.7
323.0
755
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
20.4
323.0
1280
1449
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
371.6
323.0
965
47
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
5738.3
323.0
466
*
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
409.5
323.0
348
10
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
335.3
323.0
604
25
130
Kela drug reimbursment
Malignant tumour
20.8
323.0
1197
1223
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
26.9
263.7
372
166
A03FA01
ATC
metoclopramide; systemic, rectal
5.6
259.8
986
2830
WF049
NOMESCO Finland
Radiotherapy of metastasis
14.1
227.4
409
353
L01CA04
ATC
vinorelbine; systemic
67.1
221.1
255
43
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
19.5
217.2
340
205
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
325.2
205.1
205
7
A04AA01
ATC
ondansetron; systemic, rectal
8.5
197.2
470
683
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
32.5
195.5
261
91
N02AA05
ATC
oxycodone; systemic
4.8
189.9
784
2294
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
8.2
188.7
461
693
GDC00
NOMESCO Finland
Lobectomy of lung
60.5
185.8
218
40
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
25.9
172.7
245
106
Z51.5
ICD-10 Finland
Palliative care
6.9
164.9
456
810
JN4BD
NOMESCO Finland
Extensive body CT
5.0
158.9
603
1567
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
34.0
139.7
184
59
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
31.3
136.9
184
64
GD1AD
NOMESCO Finland
Thorax CT examination
7.9
131.6
322
468
WF004
NOMESCO Finland
Palliative radiotherapy
12.7
126.1
234
205
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
122.3
1315
7488
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
19.9
122.2
188
103
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
7.6
119.3
298
444
WZC30
NOMESCO Finland
Teaching
4.1
119.2
554
1695
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.9
116.0
575
1856
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
19.6
114.5
177
98
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.4
110.8
454
1224
R84
ICPC
Malignant neoplasm bronchus/lung
54.8
108.2
129
25
C34.22
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma
231.6
107.7
110
5
155
Kela drug reimbursment
Afatinib and gefitinib
527.1
102.5
101
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
11.7
100.2
192
178
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
17.2
98.9
160
100
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
7.8
97.8
238
337
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
21.9
93.0
138
67
191
Kela drug reimbursment
Erlotinib
105.9
92.8
101
10
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.1
87.6
592
2352
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
24.5
87.3
125
54
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
20.2
87.3
133
70
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
6.2
86.6
251
452
1BA04
NOMESCO Finland
NA
221.0
82.9
85
*
WF002
NOMESCO Finland
Radical radiotherapy
4.6
76.6
287
690
B01AB05
ATC
enoxaparin; parenteral
2.5
76.4
883
4757
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
5.9
75.1
225
420
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
8.8
73.2
163
198
R03BB04
ATC
tiotropium bromide; inhalant
3.2
73.0
450
1650
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
72.3
824
4372
L01XE03
ATC
[U] erlotinib; oral
131.2
71.4
76
6
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
4.4
70.5
275
686
JN4AD
NOMESCO Finland
Body CT examination
3.8
70.1
335
1005
8140/3-C34.2
ICD-O-3
Adenocarcinoma, NOS, of middle lobe, lung
+∞
68.1
65
*
A04AA55
ATC
palonosetron, combinations; systemic
9.1
65.9
144
169
XX3DW
NOMESCO Finland
Time consuming IT work
3.3
65.6
383
1339
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
64.7
64.8
75
12
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
22.8
64.5
94
43
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
6.3
64.3
181
311
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.3
61.5
249
640
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
6.5
61.3
168
278
3004
Kela drug reimbursment
Osimertinib
+∞
60.7
58
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
6.7
60.3
161
257
C34.02
ICD-10 Finland
Malignant tumor of the main bronchial adenocarcinoma
131.8
60.2
64
5
L01XE13
ATC
[U] afatinib; oral
310.7
59.6
60
*
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
25.3
58.9
83
34
J93.8
ICD-10 Finland
Other pneumothorax
29.2
58.3
79
28
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
18.0
57.1
90
52
R4110
NOMESCO Finland
Physiotherapy
2.3
56.8
711
3843
A04AA02
ATC
granisetron; systemic, transdermal
3.9
56.5
249
690
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.2
56.4
803
4601
1519
Kela drug reimbursment
NA
+∞
55.4
53
*
TGD00
NOMESCO Finland
Needle biopsy of lung
25.2
55.3
78
32
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
30.6
55.3
74
25
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
24.7
52.2
74
31
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
13.5
52.1
92
71
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
22.8
51.7
75
34
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
50.3
688
3826
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.3
50.2
284
956
ZX050
NOMESCO Finland
Stereotactic radiotherapy
14.8
49.5
84
59
GD2CT
NOMESCO Finland
Cytology of the lungs with CT guidance
108.6
49.0
53
5
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
17.9
48.3
76
44
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
25.0
48.2
68
28
L01EB04
ATC
osimertinib; oral
+∞
48.1
46
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.7
46.8
221
646
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.6
46.8
226
674
341
Kela drug reimbursment
Afatinib and gefitinib
240.0
46.1
47
*
M05BX04
ATC
denosumab; parenteral
4.1
46.1
191
498
ZX120
NOMESCO Finland
Intravenous
2.9
46.0
316
1213
N03AX16
ATC
pregabalin; oral
2.2
45.7
593
3194
J94.8
ICD-10 Finland
Other specified pleural conditions
6.9
45.5
117
177
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
5.4
45.2
142
278
A06AH03
ATC
naloxegol; oral
9.8
45.0
93
99
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
5.8
45.0
133
242
WX892
NOMESCO Finland
Monitored bed care
3.1
43.5
267
951
B01AB10
ATC
tinzaparin; parenteral
3.3
42.6
238
791
TGA30
NOMESCO Finland
Thoracocentesis
10.1
42.0
85
87
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
42.0
561
3044
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.6
41.9
202
600
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
21.6
41.5
61
29
WX250
NOMESCO Finland
Intercostal blockade
40.2
40.7
51
13
XG410
NOMESCO Finland
Flow-volume spirometry
4.0
40.4
173
464
GD2AT
NOMESCO Finland
Cytology of the lungs with ultrasound guidance
33.2
39.9
52
16
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
7.0
39.0
99
147
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
7.5
38.4
93
129
L01XE02
ATC
[U] gefitinib; oral
+∞
37.6
36
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
24.6
37.6
53
22
J01MA14
ATC
moxifloxacin; systemic
2.7
37.3
277
1106
N02AX02
ATC
tramadol; systemic, rectal
1.8
37.1
1004
7011
H02AB06
ATC
prednisolone; systemic
1.8
36.9
1074
7680
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
5.9
36.8
106
187
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
20.5
36.2
54
27
C34.2
ICD-10 Finland
Malignant neoplasm: Middle lobe, bronchus or lung
30.6
36.1
48
16
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
25.5
35.9
50
20
JN4CD
NOMESCO Finland
Very extensive body CT
3.8
35.6
160
447
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.3
35.1
188
605
1623C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,ADENOCARCINOMA]
342.3
34.0
34
*
C34.20
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung without histology
36.5
33.8
43
12
J01MA12
ATC
levofloxacin; systemic
2.0
33.3
522
2979
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
17.6
31.9
50
29
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
13.7
31.8
55
41
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
6.0
31.7
90
156
N02AA01
ATC
morphine; systemic, rectal
6.0
31.7
90
156
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
27.4
31.5
43
16
ZX090
NOMESCO Finland
Other technic of radiotherapy
4.1
31.5
128
327
N07BA03
ATC
varenicline; oral
4.3
31.2
120
291
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
31.1
463
2578
C34
ICD-10 Finland
Malignant neoplasm of bronchus and lung
33.1
30.0
39
12
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
15.3
29.1
48
32
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
13.9
28.6
49
36
J93.9
ICD-10 Finland
Pneumothorax, unspecified
19.0
28.3
43
23
1504
Kela drug reimbursment
Alectinib
+∞
28.2
27
*
3001
Kela drug reimbursment
Alectinib
+∞
28.2
27
*
GEA00
NOMESCO Finland
Mediastinoscopy
22.6
27.9
40
18
A04AD12
ATC
aprepitant; systemic
5.8
27.7
80
142
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
9.3
27.7
58
64
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.9
27.6
92
193
R03AC02
ATC
salbutamol; inhalant
1.7
27.2
1018
7574
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
5.4
27.2
83
158
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
4.1
27.0
109
277
A79
ICPC
Malignancy NOS
5.9
26.8
76
132
GDC10
NOMESCO Finland
Bilobectomy of lung
141.7
26.7
28
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
7.9
26.5
61
79
A98
ICPC
Health maint/preventive medicine
0.6
26.4
1478
17020
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.7
26.3
186
717
L01XE35
ATC
[U] osimertinib; oral
+∞
26.1
25
*
169
Kela drug reimbursment
Crizotinib
+∞
26.1
25
*
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
6.9
25.4
64
95
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
8.9
25.3
54
62
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
7.3
25.1
61
86
A02BC02
ATC
pantoprazole; systemic
1.6
24.7
1368
11160
B03BA03
ATC
hydroxocobalamin; parenteral
2.5
24.5
202
852
L01ED03
ATC
alectinib; oral
+∞
24.0
23
*
L01EB03
ATC
afatinib; oral
+∞
24.0
23
*
R06.0
ICD-10 Finland
Dyspnoea
1.7
23.6
593
3900
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
7.3
23.6
57
80
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
6.3
23.1
62
101
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
16.6
22.7
36
22
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.6
22.6
178
732
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.1
22.5
275
1398
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
6.6
22.1
57
88
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.6
21.9
171
699
L01XE16
ATC
[U] crizotinib; oral
+∞
21.9
21
*
R04.2
ICD-10 Finland
Haemoptysis
3.0
21.9
128
438
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
21.6
373
2166
1CD01
NOMESCO Finland
NA
28.3
20.9
28
10
8140/3-C34.0
ICD-O-3
Adenocarcinoma, NOS, of main bronchus
+∞
20.9
20
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
5.7
20.4
59
106
TGC00
NOMESCO Finland
Bronchial lavation
3.5
20.0
95
279
L01XE36
ATC
[U] alectinib; oral
+∞
19.8
19
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
7.3
19.6
47
66
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
19.4
903
6887
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
6.7
19.4
49
74
B01AB04
ATC
dalteparin; parenteral
2.6
19.3
144
572
C34.0
ICD-10 Finland
Malignant neoplasm: Main bronchus
11.8
19.3
35
30
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
19.2
290
1596
GDC11
NOMESCO Finland
Thoracoscopic bilobectomy of lung
191.5
18.6
19
*
D38.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified
16.3
18.3
29
18
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
10.4
18.1
35
34
PJD99
NOMESCO Finland
Excision of other lymph nodes
26.9
17.8
24
9
5826
FHL
Lobectomy or bilobectomy
15.7
17.5
28
18
GDD00
NOMESCO Finland
Pneumonectomy
29.0
17.4
23
8
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
5.3
17.1
52
100
C34.89
ICD-10 Finland
Malignant overall tumor of the bronchus and lung other or unspecified histology
16.1
17.0
27
17
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
16.4
16.5
26
16
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
40.4
16.3
20
5
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
3.3
16.0
81
251
GAC00
NOMESCO Finland
Biopsy of pleura
9.0
15.9
33
37
ZXA00
NOMESCO Finland
Right side
1.5
15.2
601
4353
R03AK07
ATC
formoterol and budesonide; inhalant
1.7
15.1
344
2163
C34.13
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary bronchoalveolar carcinoma
45.3
15.1
18
*
WW200
SPAT
NA
0.3
14.9
25
913
J86.9
ICD-10 Finland
Pyothorax without fistula
5.9
14.8
41
71
WX402
NOMESCO Finland
General anaesthesia
1.8
14.8
300
1821
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
6.9
14.7
36
53
WX330
NOMESCO Finland
Paravertebral ansthesia
+∞
14.6
14
*
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
8.5
14.5
31
37
C34.29
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung other or unspecified histology
22.4
14.2
20
9
ZX070
NOMESCO Finland
Intensity modified radiotherapy
3.2
13.9
72
229
L03AA13
ATC
pegfilgrastim; parenteral
2.7
13.8
91
340
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.3
13.7
23
840
N06DX01
ATC
memantine; oral
0.3
13.6
29
941
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.6
13.6
322
4680
363
Kela drug reimbursment
Crizotinib
+∞
13.5
13
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
3.8
13.5
56
149
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
34.2
13.5
17
5
C34.01
ICD-10 Finland
Malignant tumor of the main bronchial epidermoid carcinoma
12.9
13.4
23
18
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
12.9
13.4
23
18
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
9.7
13.2
26
27
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
19.1
12.9
19
10
ZX080
NOMESCO Finland
Image guided radiotherapy
3.5
12.9
60
176
SPAT1109
SPAT
Analgesia with portable analgesic pump
7.0
12.9
31
45
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
3.9
12.8
52
136
R85
ICPC
Malignant neopl respiratory other
14.1
12.7
21
15
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
12.6
374
2517
8140/3-C34.8
ICD-O-3
Adenocarcinoma, NOS, of overlapping lesion of lung
+∞
12.5
12
*
1625C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,ADENOCARCINOMA]
+∞
12.5
12
*
J43.9
ICD-10 Finland
Emphysema, unspecified
3.4
12.5
60
181
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.6
12.4
312
4496
TXQ05
NOMESCO Finland
Puncture of skin, site unspecified
130.7
12.4
13
*
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
5.6
12.4
35
63
A06AD11
ATC
lactulose; oral
1.6
12.3
358
2397
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
12.2
302
1937
N05CF01
ATC
zopiclone; oral
1.4
11.9
685
5309
C34.09
ICD-10 Finland
Malignant tumor of the main bronchus other or unspecified histology
13.4
11.9
20
15
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.2
11.9
119
554
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.6
11.8
205
3206
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
0.7
11.7
581
7397
R2110
NOMESCO Finland
Giving the first information
2.2
11.6
121
572
F03
ICD-10 Finland
Unspecified dementia
0.2
11.6
14
615
325
Kela drug reimbursment
Erlotinib
65.3
11.6
13
*
SPAT1053
SPAT
Memory test
0.6
11.5
174
2810
SFA10
NOMESCO Finland
Fillning on one surface of tooth
0.7
11.5
551
7063
GD2FN
NOMESCO Finland
Lung ventilation distribution isotope examination (radiospirometry)
120.6
11.4
12
*
C38.4
ICD-10 Finland
Malignant neoplasm: Pleura
120.6
11.4
12
*
L01EB01
ATC
gefitinib; oral (epidermal growth factor receptor (egfr) tyrosine kinase inhibitors)
120.6
11.4
12
*
RS221
NOMESCO Finland
NA
4.1
11.4
43
106
1BC05
NOMESCO Finland
NA
35.2
11.3
14
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.1
11.2
123
597
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
1.8
11.1
181
1021
GDA21
NOMESCO Finland
Thoracoscopic excision of lesion of lung
25.1
11.1
15
6
C34.33
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung bronchoalveolar carcinoma
25.1
11.1
15
6
C34.91
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma
13.9
11.0
18
13
N06DA02
ATC
donepezil; oral
0.3
11.0
26
801
R50.9
ICD-10 Finland
Fever, unspecified
1.6
10.8
272
1750
WW500
NOMESCO Finland
Blood transfusion
2.3
10.8
100
449
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
10.8
374
2607
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
9.6
10.7
21
22
GA2AT
NOMESCO Finland
Pleural biopsy with ultrasound guidance
28.1
10.7
14
5
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
17.9
10.7
16
9
D38.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pleura
17.9
10.7
16
9
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
4.8
10.7
34
71
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
7.0
10.6
25
36
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
2.4
10.5
90
389
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
3.7
10.5
44
120
SAA02
NOMESCO Finland
Basic examination of mouth
0.7
10.4
696
8508
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
10.3
389
2756
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
8.8
10.3
21
24
JN6AD
NOMESCO Finland
CT of torso and neck
4.0
10.2
39
98
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.7
10.2
441
5778
C34.21
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung epidermoid carcinoma
13.2
10.1
17
13
R52.0
ICD-10 Finland
Acute pain
2.8
10.1
63
226
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.3
10.1
96
437
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
10.0
140
750
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
7.3
10.0
23
32
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.3
10.0
18
631
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
12.2
9.8
17
14
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
2.7
9.8
66
251
SAA01
NOMESCO Finland
Simple examination of mouth
0.7
9.7
831
9839
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
13.4
9.7
16
12
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.2
9.6
90
410
GAA31
NOMESCO Finland
Thoracoscopy
8.4
9.5
20
24
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
0.4
9.3
49
1088
GDB10
NOMESCO Finland
Wedge resection of lung
9.5
9.3
18
19
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
3.6
9.2
40
113
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.6
9.2
248
1625
WW200
NOMESCO Finland
Immunization
2.8
9.1
57
206
TPH07
NOMESCO Finland
Cathetrisation of artery
1.6
9.1
236
1532
P20
ICPC
Memory disturbance
0.6
9.0
119
1997
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.2
9.0
85
387
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
2.6
8.9
62
242
WF099
NOMESCO Finland
Other radiotherapy
5.2
8.9
26
50
OAB42
SPAT
NA
0.2
8.9
6
375
N06DA03
ATC
rivastigmine; oral, transdermal
0.3
8.8
13
505
C34.15
ICD-10 Finland
Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma
10.7
8.8
16
15
N03AX14
ATC
levetiracetam; systemic
2.7
8.7
59
225
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
8.6
642
5144
R03BB01
ATC
ipratropium bromide; inhalant
1.9
8.6
118
627
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
0.2
8.6
12
480
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.7
8.5
326
4382
K02.1
ICD-10 Finland
Caries of dentine
0.7
8.5
600
7341
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.2
8.5
11
460
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
0.7
8.5
414
5349
C34.35
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma
20.1
8.5
12
6
WX600
NOMESCO Finland
Single shot through catheter
4.1
8.5
31
76
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
5.4
8.4
24
45
C34.23
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung bronchoalveolar carcinoma
90.4
8.4
9
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
3.0
8.4
46
156
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
8.3
612
4889
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
3.7
8.1
34
94
GCA32
NOMESCO Finland
Endoscopic insertion of stent into bronch
22.1
8.0
11
5
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.7
7.9
52
197
R95
ICPC
Chron obstructive pulmonary disease
2.2
7.9
78
362
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.4
7.8
27
705
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
5.4
7.8
22
41
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.7
7.8
50
187
I31.3
ICD-10 Finland
Pericardial effusion (noninflammatory)
7.0
7.8
18
26
C39.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the respiratory system
45.1
7.7
9
*
205
Kela drug reimbursment
Chronic hypertension
0.7
7.7
449
5660
N05BA04
ATC
oxazepam; oral
1.4
7.6
430
3282
XX9XW
NOMESCO Finland
NA
5.2
7.5
22
43
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
10.1
7.5
14
14
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.6
7.5
173
2559
Z72.0
ICD-10 Finland
Tobacco use
2.8
7.5
46
169
GA2CT
NOMESCO Finland
Pleural biopsy with CT guidance
80.3
7.4
8
*
G20
ICD-10 Finland
Parkinson disease
0.3
7.3
11
426
L01ED01
ATC
crizotinib; oral
+∞
7.3
7
*
1629C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,ADENOCARCINOMA]
+∞
7.3
7
*
1XC18
NOMESCO Finland
NA
+∞
7.3
7
*
QBC00
NOMESCO Finland
Removal of foreign body from skin of trunk or subcutaneous tissue
10.9
7.3
13
12
J94.9
ICD-10 Finland
Pleural condition, unspecified
5.2
7.2
21
41
SDA01
NOMESCO Finland
Simple parodonthologic therapy
0.7
7.2
188
2713
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.5
7.2
55
1071
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.5
7.2
51
204
S27.0
ICD-10 Finland
Traumatic pneumothorax
4.2
7.1
25
60
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
3.1
7.1
36
117
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.8
7.0
106
586
ZXA05
NOMESCO Finland
Left side
1.3
7.0
510
4046
L03AA02
ATC
filgrastim; parenteral
2.3
7.0
60
264
JN4DD
NOMESCO Finland
Scout CT scan of torso
10.0
7.0
13
13
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
3.8
7.0
27
71
1CD02
NOMESCO Finland
NA
4.5
6.9
23
52
L03AA14
ATC
lipegfilgrastim; parenteral
2.9
6.9
40
140
R02
ICPC
Shortness of breath/dyspnoea
1.5
6.9
223
1525
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
0.2
6.9
9
373
SPAT1312
SPAT
General health counselling
0.7
6.9
338
4380
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.7
6.8
44
165
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
2.3
6.8
61
275
1623X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,EI HIST/SYTOL DG]
11.0
6.8
12
11
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
4.5
6.8
22
49
C34.14
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary macrocellular anaplastic carcinoma
40.2
6.8
8
*
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.6
6.7
123
1910
GWE00
NOMESCO Finland
Reoperation for deep haemorrhage in thoracic surgery
16.7
6.7
10
6
1240
FHL
Bronchoscopy
3.0
6.7
35
116
ZYC01
SPAT
NA
0.3
6.7
12
420
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
4.7
6.7
21
45
L57.0
ICD-10 Finland
Actinic keratosis
0.6
6.7
96
1574
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
4.0
6.6
24
60
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.5
6.6
200
1349
Z01.2
ICD-10 Finland
Dental examination
0.7
6.5
395
4978
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.5
6.5
207
1407
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
4.8
6.5
20
42
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
0.6
6.5
70
1236
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.0
6.5
*
161
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
3.4
6.4
28
82
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
3.0
6.4
34
115
SPAT1249
SPAT
Treatment-related counselling outside office
0.8
6.4
481
5885
B01AF01
ATC
rivaroxaban; oral
0.6
6.4
117
1814
N40
ICD-10 Finland
Hyperplasia of prostate
0.7
6.4
384
4840
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
8.2
6.3
13
16
UGB02
NOMESCO Finland
Tracheoscopy
8.2
6.3
13
16
L15
ICPC
Knee symptom/complaint
0.7
6.3
194
2720
J01AA02
ATC
doxycycline; systemic
1.3
6.3
1482
13650
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
9.3
6.3
12
13
3017
Kela drug reimbursment
Brigatinib
+∞
6.2
6
*
1628C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,ADENOCARCINOMA]
+∞
6.2
6
*
GEB40
NOMESCO Finland
Mediastinotomy and extended excision of lesion
+∞
6.2
6
*
XG466
NOMESCO Finland
Sleep oxymetry
2.1
6.2
68
333
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.8
6.1
98
552
A04AA03
ATC
tropisetron; systemic
5.7
6.1
16
28
J85.2
ICD-10 Finland
Abscess of lung without pneumonia
7.7
6.1
13
17
HA1AA
NOMESCO Finland
X-ray mammography
1.7
6.1
114
676
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
6.1
302
2246
C10AA07
ATC
rosuvastatin; oral
0.7
6.1
287
3754
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
3.3
6.1
28
86
A02BC01
ATC
omeprazole; systemic
1.3
6.0
549
4491
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
390
283
16.39
307.65
1.2
1.1
—
—
—
0
0
(4035726)
940
1711
8.59
307.65
1.5
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
406
478
10.10
307.65
1.4
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
735
2325
4.17
204.94
4.4
4.0
ug/l
98.1
23.4
2.19
679
1933
(3003434) Protein [Mass/volume] in Pleural fluid
268
351
8.51
195.70
1.4
1.5
g/l
38.7
31.4
13.69
252
320
(40768806) Pleura Pathology biopsy report
235
268
9.65
191.48
1.6
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
393
794
5.76
189.66
2.1
2.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
867
3295
3.62
181.55
4.6
3.1
mmol/l
0.8
0.8
9.86
840
3056
(3023199) Leukocytes [#/volume] in Pleural fluid
243
313
8.56
179.59
1.5
1.4
e6/l
2796.3
2030.3
0.72
187
218
(3028308) Erythrocytes [#/volume] in Pleural fluid
227
284
8.76
171.66
1.5
1.4
e6/l
69719.2
89769.6
0.25
152
165
(3012441) Differential panel - Pleural fluid
221
275
8.78
167.79
1.5
1.5
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
171
9
205.08
166.33
1.1
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
189
197
10.36
164.21
1.5
1.5
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
185
244
8.16
133.38
1.3
1.4
mmol/l
5.7
6.5
1.84
172
229
(3045788) Cell count panel - Pleural fluid
186
247
8.10
133.33
1.5
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
208
316
7.14
132.34
1.6
2.7
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
157
183
9.13
125.03
1.2
1.3
u/l
12.2
15.6
0.65
149
168
(4010399)
422
1344
3.62
110.36
1.4
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
224
456
5.33
105.23
1.3
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
1148
6468
2.55
103.62
7.0
5.6
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
447
1549
3.34
101.81
5.6
2.2
nmol/l
413.4
370.5
3.57
434
1391
(3022096) Basophils/100 leukocytes in Blood
1357
8338
2.53
100.54
7.2
5.9
%
0.6
0.7
4.57
1324
7699
(3018677) aPTT in Platelet poor plasma by Coagulation assay
706
3263
2.68
94.68
2.2
2.0
s
29.9
30.1
0.25
697
3160
(3019069) Monocytes/100 leukocytes in Blood
1364
8593
2.44
92.74
7.4
6.2
%
9.1
9.0
0.55
1334
7956
(3006504) Eosinophils/100 leukocytes in Blood
1360
8561
2.44
92.56
7.3
5.9
%
2.5
2.9
6.83
1330
7892
(3002030) Lymphocytes/100 leukocytes in Blood
1373
8734
2.42
90.43
7.3
6.0
%
22.4
26.1
28.18
1342
8033
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
593
2599
2.73
87.48
4.4
3.9
u/l
255.5
247.2
0.51
579
2435
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
127
176
7.58
87.34
1.3
1.4
u/l
10.3
13.7
6.34
118
166
(3013650) Neutrophils [#/volume] in Blood by Automated count
1559
10604
2.46
86.58
16.7
8.9
e9/l
4.8
4.3
12.25
1412
9197
(3018010) Neutrophils/100 leukocytes in Blood
1341
8590
2.34
84.75
7.1
5.8
%
62.1
58.4
21.39
1311
7944
(3033658) Prothrombin time (PT) actual/Normal
890
4786
2.40
84.61
5.7
4.0
%
93.0
84.2
23.88
880
4669
(3001604) Monocytes [#/volume] in Blood
1385
9035
2.34
83.27
7.2
5.5
e9/l
0.7
0.6
18.55
1210
7679
(3018418) pH of Serum or Plasma
1044
6062
2.32
82.59
6.0
4.1
ph
7.4
7.4
1.37
184
1187
(3006315) Basophils [#/volume] in Blood
1387
9084
2.32
82.17
7.2
5.5
e9/l
0.0
0.0
1.22
1217
7730
(3032080) INR in Blood by Coagulation assay
1359
8834
2.31
81.83
7.2
11.3
inr
1.2
1.4
6.18
262
2436
(3035880) pH of Pleural fluid
111
146
7.94
79.80
1.2
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
1396
9238
2.30
79.67
7.3
5.6
e9/l
1.8
1.9
0.49
1237
8006
(3013115) Eosinophils [#/volume] in Blood
1410
9376
2.30
79.43
7.4
5.7
e9/l
0.2
0.2
0.74
1243
8107
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1487
10217
2.29
75.85
12.1
6.3
umol/l
9.7
12.2
13.48
1460
9680
(3023368) Bacteria identified in Blood by Culture
1033
6149
2.23
74.94
4.8
4.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1380
9330
2.20
71.36
8.6
5.9
mmol/l
1.2
1.2
2.92
1322
8364
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1463
10184
2.20
69.40
10.1
6.9
mmol/l
1.2
1.2
0.83
1261
8502
(3009214) Lutropin [Units/volume] in Serum or Plasma
132
244
5.68
68.52
1.3
1.3
u/l
14.6
10.4
1.90
106
191
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1310
16954
0.47
64.44
3.8
4.8
mmol/l
1.4
1.4
1.99
1101
15176
(40758558) Short blood count panel - Blood
814
4615
2.18
64.39
12.1
6.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1131
7312
2.07
62.82
2.9
2.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1290
16741
0.48
62.79
5.6
6.6
mmol/mol
40.9
40.9
0.10
1102
15164
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1339
17127
0.48
61.73
3.7
4.8
mmol/l
4.5
4.4
0.47
1134
15473
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
107
179
6.22
61.53
1.2
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1407
17604
0.48
58.29
4.2
5.5
mmol/l
2.6
2.6
1.50
1177
15806
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
66
67
10.11
57.96
1.2
1.3
ug/l
716.8
121.2
2.35
55
29
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
703
3928
2.14
56.32
6.1
3.1
mmol/l
2.5
2.5
20.69
654
3442
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1274
16416
0.50
56.12
3.4
4.3
mmol/l
1.3
1.3
0.72
1064
14551
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
902
5571
2.02
54.73
4.6
3.2
u/l
30.3
37.3
2.85
874
5276
(3042936) Bacteria identified in Isolate by Culture
552
2893
2.19
51.42
1.9
2.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
100
189
5.49
50.59
1.4
1.3
iu/l
30.8
33.2
0.26
80
158
(3024561) Albumin [Mass/volume] in Serum or Plasma
1251
8799
1.92
50.45
6.4
4.8
g/l
32.8
34.6
20.92
1189
8115
(3023383) Lactate [Moles/volume] in Pleural fluid
64
75
8.75
50.45
1.2
1.4
mmol/l
3.7
3.6
0.05
59
67
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
109
246
4.60
44.87
2.8
3.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1006
6776
1.86
44.54
6.4
3.4
mmol/l
2.4
2.3
5.15
934
5780
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
276
1161
2.56
41.91
9.0
8.4
mmol/l
25.0
24.3
3.60
267
1081
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
66
103
6.57
40.57
1.3
1.5
%
62.7
67.2
0.43
57
82
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
178
606
3.10
40.25
1.5
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
216
830
2.77
39.21
2.3
2.6
u/ml
0.3
0.3
0.01
121
482
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
753
4775
1.86
39.21
2.6
2.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1452
17397
0.55
38.33
4.9
5.1
mmol/l
6.1
6.1
0.63
1235
15435
(3044640) Blood type and Crossmatch panel - Blood
914
6209
1.78
37.51
2.7
2.6
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
49
62
8.05
36.28
1.3
1.3
%
20.0
24.3
0.40
42
47
(3001893) Eosinophils/100 leukocytes in Pleural fluid
57
88
6.62
35.40
1.3
1.5
%
6.6
2.5
1.33
51
75
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
342
1700
2.19
35.20
2.8
2.4
u/l
32.4
38.2
0.85
299
1446
(3013826) Glucose [Moles/volume] in Serum or Plasma
1465
11581
1.73
33.39
7.5
4.9
mmol/l
6.7
6.9
3.22
1421
10932
(3021589) Normoblasts [#/volume] in Blood
1081
7911
1.69
32.52
14.3
10.4
e9/l
0.0
0.0
0.33
869
6415
(3014111) Lactate [Moles/volume] in Serum or Plasma
357
1860
2.09
32.37
7.6
6.3
mmol/l
1.2
1.4
4.90
338
1786
(3002256) Pathology report gross observation
444
2507
1.96
32.12
1.4
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
72
156
4.73
31.15
1.5
1.6
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
442
2561
1.90
29.34
7.7
6.7
kpa
5.2
5.1
2.75
416
2433
(3027801) Oxygen [Partial pressure] in Arterial blood
440
2562
1.89
28.71
7.7
6.6
kpa
11.4
11.8
0.79
412
2434
(3000492) Spirometry study
278
1375
2.16
28.68
1.6
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
440
2568
1.88
28.48
7.7
6.6
mmol/l
1.3
1.1
0.40
372
1975
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
252
4762
0.47
28.16
1.6
1.6
mmol/l
1.4
1.3
0.50
218
3894
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
572
3633
1.76
27.97
1.8
1.9
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
110
356
3.19
27.03
1.4
1.8
iu/l
3.4
4.4
0.50
13
115
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
614
4081
1.69
25.06
4.7
4.1
ng/l
368.0
599.2
0.44
543
3511
(3009508) Creatinine [Moles/volume] in Urine
409
6401
0.56
24.30
2.8
3.2
mmol/l
7.1
7.2
0.27
321
5268
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
123
454
2.81
23.98
1.2
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
123
454
2.81
23.98
1.2
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
438
6688
0.57
23.59
3.5
4.0
mg/mmol
14.8
8.9
1.21
281
4255
(3012516) Albumin [Mass/volume] in Urine
408
6329
0.57
23.21
2.9
3.3
mg/l
326.4
279.9
0.10
270
4060
(3014576) Chloride [Moles/volume] in Serum or Plasma
438
2719
1.75
22.64
7.8
6.4
mmol/l
104.0
104.3
0.67
431
2638
(3000991) Gas panel - Venous blood
315
1780
1.89
22.13
8.9
7.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
92
305
3.10
21.73
1.7
2.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
86
276
3.20
21.45
1.4
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
100
351
2.93
21.39
1.4
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
141
597
2.45
20.84
3.9
3.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
92
313
3.02
20.80
1.4
1.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1725
19091
0.62
20.79
44.0
25.6
g/l
125.9
133.2
75.16
1691
18698
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
102
368
2.85
20.76
1.4
1.7
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1725
19088
0.62
20.72
43.7
25.4
e12/l
4.2
4.4
38.74
1667
18393
(3024731) MCV [Entitic volume]
1725
19087
0.62
20.69
43.6
25.3
fl
91.7
91.8
0.61
1687
18694
(3035941) MCH [Entitic mass]
1725
19087
0.62
20.69
43.6
25.3
pg
30.1
30.5
11.53
1686
18693
(3007461) Platelets [#/volume] in Blood
1725
19084
0.62
20.62
43.8
25.4
e9/l
272.2
239.7
52.43
1675
18472
(3010813) Leukocytes [#/volume] in Blood
1726
19092
0.62
20.60
43.8
25.4
e9/l
8.0
6.9
32.19
1664
18398
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
470
6858
0.60
20.39
4.0
4.7
%
19.9
22.1
2.71
243
3659
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
86
287
3.07
20.10
1.4
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
629
8558
0.64
20.06
4.6
5.5
ug/l
2.5
4.3
2.80
535
7526
(3020630) Protein [Mass/volume] in Serum or Plasma
332
1968
1.80
19.90
1.7
2.7
g/l
63.9
66.2
6.24
306
1791
(1761868) Lipid panel - Serum or Plasma
305
4934
0.56
19.51
3.0
3.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1388
15997
0.67
18.81
6.0
4.7
mu/l
1.9
2.1
1.77
1214
14201
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
119
489
2.51
18.76
1.4
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
398
2524
1.70
18.73
1.8
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
397
2519
1.70
18.64
1.8
1.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
51
128
4.05
18.37
1.1
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
246
1360
1.91
18.35
4.2
3.6
mmol/l
2.2
1.9
0.62
199
997
(3009343) pH of Capillary blood
253
1419
1.88
18.04
4.3
3.6
ph
7.4
7.4
0.83
30
175
(3030467) Casts [#/volume] in Urine by Automated count
760
5659
1.51
18.02
3.3
3.4
e6/l
0.5
0.5
0.25
596
4376
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
195
1001
2.04
18.01
1.8
1.9
ug/l
3.1
2.7
0.08
177
869
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
121
516
2.42
17.62
1.4
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
47
115
4.15
17.52
4.5
3.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
816
6197
1.49
17.45
3.3
3.5
e6/l
50.3
98.0
1.76
646
4878
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
253
1439
1.85
17.24
4.3
3.6
kpa
5.1
5.1
0.05
237
1315
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
27
42
6.49
16.65
1.4
1.5
%
14.1
4.0
1.43
20
23
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1662
14583
1.50
16.41
17.2
7.8
u/l
88.6
81.0
7.54
1634
13620
(36304419) Bacteria [Presence] in Urine
722
5412
1.49
16.20
3.2
3.3
—
—
—
0
0
(3014891) Appearance of Pleural fluid
25
37
6.82
16.14
1.5
1.5
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
28
47
6.02
16.05
1.1
1.1
mmol/l
2.1
1.6
1.42
22
31
(3026782) Osmolality of Urine
578
4148
1.53
15.97
2.8
2.9
mosm/kgh2o
535.7
552.6
1.18
513
3524
(1616796) Gas panel - Central venous blood
115
502
2.36
15.91
3.8
4.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
473
3250
1.57
15.89
3.0
3.2
e6/l
2.0
1.9
0.26
274
1848
(3022313) Gas panel - Capillary blood
193
1035
1.94
15.72
4.5
3.7
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
156
781
2.07
15.41
2.0
2.1
ug/l
261.7
815.7
1.34
141
737
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1695
18584
0.67
15.25
21.1
11.4
u/l
24.5
25.1
0.94
1660
17714
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
212
1185
1.87
15.23
10.6
9.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
32
67
4.83
14.49
1.1
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
257
1551
1.74
14.28
3.6
4.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1716
18718
0.67
14.24
33.7
20.6
mmol/l
4.0
4.0
0.32
1674
18167
(3016502) Oxygen saturation in Arterial blood
352
2316
1.61
14.06
8.8
6.9
%
94.7
95.3
0.89
339
2224
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
34
78
4.41
13.80
1.1
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
34
78
4.41
13.80
1.1
1.9
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
560
7392
0.68
13.69
2.0
2.2
nmol/l
76.2
79.2
1.44
482
6403
(3019550) Sodium [Moles/volume] in Serum or Plasma
1716
18685
0.68
13.61
33.5
20.4
mmol/l
138.4
139.7
53.56
1680
18165
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
34
80
4.30
13.38
1.1
1.9
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
43
122
3.57
13.10
1.5
1.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
776
6100
1.41
12.84
4.7
2.5
u/l
61.8
58.0
0.68
739
5578
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
47
144
3.31
12.74
1.5
1.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
87
373
2.38
12.58
2.0
3.8
%
1.7
1.6
0.04
79
281
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
42
122
3.49
12.37
1.5
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1063
8852
1.37
12.27
3.9
4.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
151
813
1.92
12.16
2.8
3.3
u/ml
702.9
5321.9
0.75
127
698
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
690
8644
0.71
12.09
2.0
2.1
pmol/l
89.8
93.4
1.26
335
4481
(3012501) Base excess in Blood by calculation
107
511
2.15
11.99
4.5
5.0
mmol/l
3.2
2.7
0.83
85
350
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
316
4574
0.64
11.87
1.5
1.8
pmol/l
474.6
20559905.3
2.85
245
3682
(3051611) Lipemic interference index of Serum or Plasma
58
210
2.81
11.84
4.5
3.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
868
7026
1.38
11.82
3.8
4.0
e6/l
82.3
117.9
0.48
660
5198
(3002173) Hemoglobin [Mass/volume] in Arterial blood
316
2111
1.58
11.73
9.4
7.3
g/l
121.1
120.4
0.29
304
2035
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
74
306
2.47
11.60
1.5
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
64
247
2.64
11.57
2.2
4.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
512
3803
1.45
11.38
1.7
1.6
mg/l
2.3
1.5
1.81
430
2995
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
525
6838
0.70
11.36
4.0
4.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
258
1656
1.63
11.30
3.0
4.0
%
1.3
0.9
1.41
128
529
(3021901) Oxygen saturation in Capillary blood
96
451
2.18
11.23
3.1
2.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
271
3997
0.64
10.99
4.0
4.5
kg/l
1.0
1.0
0.39
42
628
(3028626) Oxygen [Partial pressure] in Capillary blood
107
530
2.07
10.93
3.4
3.0
kpa
7.9
7.8
0.45
99
480
(3006184) Hemoglobin [Mass/volume] in Capillary blood
104
510
2.09
10.91
2.1
2.2
g/l
118.1
127.9
2.62
52
367
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
81
359
2.30
10.91
3.8
3.3
%
60.4
59.0
0.36
81
359
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
21
39
5.42
10.87
5.6
2.3
u/l
30.2
39.3
0.60
14
12
(3010421) pH of Blood
117
600
2.00
10.87
4.7
4.7
ph
7.4
7.4
2.40
104
503
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
239
1520
1.64
10.85
1.5
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
244
1564
1.63
10.73
3.0
4.1
%
0.2
0.1
0.44
120
488
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
95
453
2.14
10.72
1.9
2.2
%
221.2
204.9
1.08
88
428
(3030905) Polymorphonuclear cells [#/volume] in Blood
78
344
2.31
10.63
3.3
3.1
e9/l
4.7
4.4
0.44
78
344
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
54
201
2.73
10.50
1.3
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
51
185
2.80
10.41
1.3
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
51
185
2.80
10.41
1.3
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
51
185
2.80
10.41
1.3
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
467
3463
1.44
10.37
2.9
3.0
e6/l
1.1
1.1
0.05
269
2050
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
166
975
1.76
10.12
2.7
3.8
mmol/l
24.6
24.1
0.93
160
862
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
205
1281
1.66
9.97
1.5
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
310
2136
1.52
9.95
2.8
2.8
umol/l
8.4
9.6
0.31
276
1897
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
55
213
2.62
9.92
1.3
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
231
1493
1.61
9.81
3.1
3.9
%
0.7
0.6
0.68
100
367
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
35
107
3.31
9.58
1.1
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
35
107
3.31
9.58
1.1
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
35
107
3.31
9.58
1.1
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
35
107
3.31
9.58
1.1
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
372
5023
0.69
9.52
4.1
4.3
estimate
0.0
0.0
0.50
149
1626
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1149
13042
0.76
9.22
5.3
3.9
pmol/l
15.3
15.1
2.13
1033
11508
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
146
858
1.75
8.91
4.8
3.9
mmol/l
25.5
24.8
1.83
139
791
(3021601) Nitrite [Presence] in Urine by Test strip
743
8918
0.75
8.88
5.0
5.3
estimate
0.0
0.0
0.00
171
1724
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
48
184
2.64
8.86
1.5
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
58
244
2.41
8.84
1.5
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
756
9041
0.76
8.76
3.7
4.0
estimate
0.0
0.0
1.08
162
1679
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
362
4846
0.70
8.71
3.0
3.3
ug/l
0.8
0.8
0.01
254
3486
(3036489) Thrombin time
117
652
1.84
8.53
1.8
1.8
s
21.6
21.7
0.04
107
587
(3015235) Bicarbonate [Moles/volume] in Capillary blood
111
609
1.86
8.50
3.7
3.3
mmol/l
25.1
25.0
0.06
96
524
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
169
2629
0.61
8.48
10.7
7.8
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
15
26
5.80
8.33
1.3
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
748
8913
0.76
8.28
3.6
4.0
estimate
0.0
0.0
0.00
170
1710
(40761511) CBC panel - Blood by Automated count
1668
17902
0.75
8.09
26.2
16.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
83
421
2.01
8.03
1.3
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
77
386
2.03
7.70
1.2
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
96
1663
0.56
7.30
1.3
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
21
55
3.84
7.25
1.0
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
91
497
1.87
7.12
2.6
2.5
%
14.4
15.8
2.17
42
252
(3021960) Folate [Moles/volume] in Serum or Plasma
402
5144
0.74
7.11
1.5
1.6
nmol/l
19.6
20.1
0.29
348
4314
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
95
1633
0.56
7.03
1.6
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1545
16659
0.78
6.98
30.7
16.4
ml/min/173m2
76.6
73.1
9.83
1424
13815
(3002032) Base excess in Venous blood by calculation
279
2021
1.43
6.89
3.5
3.5
mmol/l
2.1
2.0
0.11
232
1594
(3021447) Carbon dioxide [Partial pressure] in Venous blood
278
2030
1.42
6.56
3.4
3.5
kpa
5.9
5.8
0.05
269
1967
(3015736) pH of Urine
578
6967
0.77
6.55
3.4
3.7
—
6.0
—
0
7
(3003181) Sodium [Moles/volume] in Urine
73
385
1.93
6.38
1.3
1.3
mmol/l
60.5
61.1
0.04
55
307
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
145
936
1.59
6.24
1.7
2.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
208
1460
1.47
6.07
3.2
4.1
%
0.0
0.4
0.87
104
403
(3028433) Virus identified in Specimen by Culture
20
58
3.47
6.01
1.1
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
30
112
2.70
5.92
2.0
1.9
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
15
36
4.19
5.82
1.1
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
538
4424
1.28
5.71
2.6
2.7
e6/l
5.8
4.7
1.05
483
3903
(4034850)
23
602
0.38
5.57
7.1
11.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
267
1992
1.38
5.56
4.7
6.8
mmol/l
8.7
11.1
6.99
251
1879
(3003458) Phosphate [Moles/volume] in Serum or Plasma
358
2801
1.33
5.48
4.2
5.6
mmol/l
1.0
1.0
0.20
335
2575
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
238
1758
1.39
5.26
6.0
3.9
mmol/l
1.2
1.2
0.18
226
1527
(3026493) Urate [Moles/volume] in Serum or Plasma
426
5217
0.77
5.26
2.6
2.9
umol/l
6095.2
6532.2
0.06
356
4407
(3003338) MCHC [Mass/volume]
1262
13740
0.82
5.18
40.9
23.0
g/l
328.2
331.6
33.34
1244
13594
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
195
1399
1.43
5.09
1.7
1.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
247
3245
0.73
5.04
1.2
1.2
u/ml
2.2
1.6
0.21
45
806
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
127
839
1.54
4.99
1.1
1.1
iu/ml
225.3
144.8
0.58
16
293
(40768441) Liver Pathology biopsy report
30
124
2.44
4.88
1.2
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
721
6239
1.23
4.76
2.6
2.2
u/l
149.9
238.3
3.72
697
5813
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
197
2657
0.72
4.73
1.3
1.3
iu/ml
35.9
40.4
0.20
66
821
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
190
2577
0.71
4.72
3.2
4.9
%
32.2
33.1
0.54
125
1649
(3000494) Fungus identified in Specimen by Culture
282
2179
1.34
4.70
1.4
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
120
1766
0.66
4.66
4.3
3.6
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
47
241
1.97
4.55
2.1
3.6
%
59.3
57.7
0.16
39
148
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
28
117
2.41
4.47
1.2
1.2
titre
290.0
124.3
—
7
23
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
19
477
0.39
4.27
1.4
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
62
361
1.74
4.07
4.1
5.2
iu/ml
465.1
768.2
—
8
51
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
194
2560
0.74
4.06
1.2
1.2
u/ml
43.4
13.7
0.48
51
913
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
9
14
6.45
3.98
1.0
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
16
53
3.03
3.96
1.3
2.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
42
768
0.54
3.96
1.8
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
24
529
0.45
3.94
1.2
1.4
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
10
24
4.18
3.89
1.4
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
33
158
2.10
3.88
1.6
2.1
e9/l
0.8
1.0
0.84
20
89
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
28
126
2.24
3.83
2.8
3.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
369
4442
0.80
3.81
1.8
1.8
nmol/l
1036.0
1172.1
1.93
265
3303
(3010503) CD19 cells [#/volume] in Blood
25
108
2.33
3.76
1.4
2.0
e9/l
0.1
0.2
0.42
25
102
(3001122) Ferritin [Mass/volume] in Serum or Plasma
639
7267
0.83
3.73
2.7
2.8
ug/l
253.6
162.4
4.78
578
6531
(3007853) Bacteria identified in Skin by Aerobe culture
284
2274
1.28
3.66
1.5
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
122
862
1.44
3.54
1.5
1.9
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
127
905
1.43
3.52
3.1
3.2
pmol/l
4.2
4.4
1.36
119
776
(21494814) CD8 cells/100 lymphocytes in Specimen
17
63
2.71
3.49
1.6
2.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
214
1665
1.31
3.43
3.3
2.8
kpa
4.5
4.5
0.12
209
1606
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
25
113
2.23
3.41
1.5
1.5
u/l
5.1
8.1
0.55
17
59
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
25
113
2.23
3.41
1.8
2.1
%
12.0
16.3
—
6
44
(4146454)
9
256
0.35
3.29
2.9
2.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
394
4639
0.82
3.26
3.6
3.7
—
—
—
0
0
(3004451) EKG impression Narrative
25
116
2.17
3.22
1.5
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
9
20
4.51
3.11
1.0
1.0
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
17
68
2.51
3.04
1.6
2.0
%
8.8
8.2
0.09
17
63
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
351
2950
1.22
2.97
2.2
2.6
%
19.7
22.2
1.90
323
2496
(3039443) Prostate specific Ag panel - Serum or Plasma
11
293
0.37
2.92
1.4
1.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
369
4328
0.82
2.91
3.2
3.9
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
36
199
1.82
2.90
1.3
1.3
mosm/kgh2o
269.9
275.9
1.16
30
143
(4015189)
16
64
2.51
2.87
1.6
1.9
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
33
178
1.87
2.87
1.1
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
23
109
2.12
2.84
1.6
2.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
18
4.46
2.79
1.5
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
18
4.46
2.79
1.5
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
18
4.46
2.79
1.5
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
18
4.46
2.79
1.5
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
238
0.38
2.78
1.4
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
760
6868
1.16
2.78
3.0
3.1
ng/l
1432.4
1803.9
1.90
684
5964
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
33
181
1.84
2.74
1.1
1.1
u/l
57.3
59.8
0.08
27
126
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
22
432
0.50
2.70
3.5
1.8
mg/l
4.1
4.0
0.01
22
333
(3045424) Erythrocytes [Presence] in Urine
12
295
0.40
2.68
1.3
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
28
148
1.90
2.61
1.1
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
101
739
1.38
2.49
2.1
1.8
u/l
37.6
38.4
0.14
86
630
(3044889) 12 lead EKG panel
1237
13107
0.88
2.47
5.0
4.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
55
823
0.66
2.44
1.8
2.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
361
3113
1.19
2.34
2.1
2.5
g/l
2.2
2.3
2.42
339
2870
(3048689) Calprotectin [Mass/mass] in Stool
133
1705
0.77
2.33
2.0
2.1
ug/g
191.0
161.3
0.27
103
1316
(40760892) CBC W Ordered Manual Differential panel - Blood
414
3614
1.18
2.33
5.4
4.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
202
1646
1.25
2.31
1.3
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
215
0.42
2.31
1.7
1.5
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
11
41
2.69
2.27
1.1
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
20
99
2.03
2.26
1.4
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
20
99
2.03
2.26
1.4
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
248
2945
0.82
2.23
1.5
1.5
g/l
2.4
2.7
1.59
123
1687
(44806118)
38
233
1.64
2.20
1.7
1.5
—
—
—
0
0
(44790049)
38
233
1.64
2.20
1.7
1.5
—
—
—
0
0
(44790048)
38
233
1.64
2.20
1.7
1.5
—
—
—
0
0
(44790047)
38
233
1.64
2.20
1.7
1.5
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
11
254
0.43
2.17
2.0
1.8
pmol/l
154.4
199.6
2.13
11
234
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
17
334
0.51
2.15
1.5
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
759
8237
0.88
2.11
2.4
2.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
25
139
1.81
2.05
1.1
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
28
467
0.59
2.04
1.1
1.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
380
3345
1.16
1.93
2.2
2.5
umol/l
10.5
12.4
4.10
358
3087
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
14
65
2.16
1.88
1.2
1.5
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
19
343
0.55
1.87
1.5
1.7
nmol/l
44.8
45.7
0.07
19
323
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
34
213
1.61
1.85
1.1
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
54
0.00
1.85
0.0
1.3
—
9.8
—
0
54
(3033705) Calcium.ionized [Moles/volume] in Venous blood
43
285
1.52
1.85
3.3
2.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
67
486
1.39
1.82
1.4
1.6
iu/ml
120.0
13.5
0.42
24
100
(3035320) C reactive protein [Mass/volume] in Body fluid
22
123
1.80
1.80
2.5
2.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
16
80
2.01
1.80
1.2
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
227
1931
1.19
1.75
2.1
2.1
g/l
0.2
0.2
0.31
206
1787
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
23
132
1.75
1.73
1.4
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
313
2742
1.16
1.71
2.2
2.4
%
1.8
1.8
0.23
280
2403
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
20
345
0.58
1.70
1.7
3.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
23
133
1.74
1.70
1.4
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
126
1556
0.80
1.69
5.0
2.9
ml/min/173m2
58.7
59.6
0.12
50
665
(3008898) HLA-B27 [Presence]
20
343
0.58
1.67
1.0
1.1
—
—
—
0
0
(3019225) pH of Specimen
253
2187
1.18
1.64
7.2
4.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
11
49
2.25
1.63
1.8
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
48
675
0.70
1.62
1.0
1.0
—
—
—
0
0
(3036603) Volume of Urine
21
120
1.76
1.62
1.4
1.3
ml
2237.5
1891.4
—
8
26
(3009542) Hematocrit [Volume Fraction] of Blood
1449
15021
0.90
1.54
34.0
18.7
%
37.8
38.5
2.25
963
9140
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
31
200
1.56
1.54
1.2
1.2
u/ml
2.4
3.5
—
7
61
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
43
0.00
1.52
0.0
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
61
452
1.36
1.50
1.4
2.5
umol/l
30.7
34.2
0.98
47
379
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
17
94
1.81
1.47
1.0
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
7
28
2.50
1.45
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
20
117
1.72
1.45
1.3
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
851
8004
1.10
1.43
4.5
4.2
ng/l
31.3
64.3
2.79
699
6240
(3002523) Influenza virus A Ag [Presence] in Specimen
20
118
1.70
1.41
1.3
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
19
111
1.72
1.39
1.7
2.1
e6/l
460.8
658.1
—
10
54
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
41
573
0.71
1.38
1.3
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1715
17591
0.90
1.38
33.1
17.3
mg/l
36.2
27.1
20.95
1634
14360
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
122
1471
0.82
1.35
1.6
1.7
%
1.6
1.6
0.12
102
1219
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
237
2074
1.16
1.35
2.9
2.9
ng/l
234.4
236.9
0.03
214
1901
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
29
191
1.52
1.34
1.2
1.2
u/ml
2.1
5.2
—
10
84
(3051101) Glucose [Moles/volume] in Cord blood
0
37
0.00
1.34
0.0
5.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
110
898
1.24
1.34
1.1
1.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
41
0.00
1.31
0.0
1.7
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
18
2.78
1.28
1.0
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
87
1080
0.80
1.28
2.4
2.5
au/ml
11.7
15.3
—
6
32
(4024509)
11
202
0.54
1.22
1.4
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
29
198
1.47
1.17
1.1
1.3
nmol/l
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
17
273
0.62
1.16
1.1
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
27
182
1.49
1.16
1.2
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
23
344
0.67
1.15
1.9
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
72
1.81
1.15
2.0
2.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
19
118
1.62
1.14
1.6
3.5
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
36
0.00
1.14
0.0
2.0
—
2.1
—
0
19
(44816559) Phosphatidylethanol [Mass/volume] in Blood
14
234
0.60
1.13
1.1
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
165
1427
1.17
1.13
6.9
6.6
mmol/l
25.4
24.5
2.92
153
1335
(4306422)
27
184
1.47
1.11
1.3
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
144
1674
0.85
1.10
2.0
2.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
95
1146
0.82
1.10
1.1
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
45
593
0.75
1.09
1.4
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
24
160
1.51
1.09
1.3
1.3
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
9
163
0.55
1.08
1.2
1.2
nmol/l
0.9
1.4
—
9
142
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
42
313
1.35
1.06
1.1
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
10
52
1.93
1.06
1.1
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
11
192
0.57
1.05
1.8
1.4
%
19.8
26.2
0.43
11
118
(3000012) Reticulocyte production index
6
124
0.48
1.04
1.8
1.5
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
22
2.28
1.03
1.8
1.5
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
83
680
1.23
1.03
3.7
3.9
mmol/l
3.9
3.9
0.19
78
623
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
11
60
1.84
1.02
4.5
3.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
9
48
1.88
1.00
1.2
1.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
7
35
2.00
1.00
1.4
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
57
450
1.27
0.98
1.7
2.7
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
30
0.00
0.97
0.0
2.3
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
31
0.00
0.96
0.0
2.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
112
1310
0.85
0.95
2.5
3.3
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
32
0.00
0.95
0.0
1.8
—
147.9
—
0
32
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
504
5380
0.92
0.94
2.2
2.2
mg/l
3.4
3.1
1.62
423
4521
(3039162) Centromere protein B Ab [Units/volume] in Serum
12
196
0.61
0.92
1.2
1.2
—
74.6
—
0
8
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
10
55
1.82
0.92
1.7
2.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
29
2.07
0.89
1.0
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
30
2.00
0.87
1.0
1.2
—
—
—
0
0
(4094501)
37
481
0.77
0.86
1.1
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
8
44
1.82
0.86
1.0
1.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
66
542
1.22
0.84
3.5
3.2
nmol/l
0.8
0.8
0.05
50
415
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
30
222
1.36
0.83
3.2
2.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
10
57
1.76
0.83
1.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
8
47
1.70
0.80
1.4
1.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
33
429
0.77
0.78
1.1
1.2
u/ml
3.2
4.0
—
5
41
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1007
10421
0.94
0.78
5.3
3.2
u/l
70.1
56.8
2.12
929
9450
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
45
561
0.80
0.77
2.2
2.3
ug/min
95.0
91.3
0.04
26
332
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
26
348
0.74
0.76
1.4
1.6
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
28
0.00
0.76
0.0
1.5
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
28
0.00
0.76
0.0
1.2
—
46.5
—
0
8
(3003327) Ova and parasites identified in Stool by Light microscopy
34
437
0.77
0.75
1.7
1.6
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
56
459
1.23
0.75
1.5
1.5
g/l
0.2
0.2
0.12
49
438
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
34
436
0.78
0.74
1.1
1.2
u/ml
10.3
7.5
—
6
67
(3023520) Reticulocytes [#/volume] in Blood
227
2073
1.11
0.73
2.4
2.5
e9/l
72.8
68.5
0.77
140
1603
(3037467) Urinalysis macro (dipstick) panel - Urine
1249
12825
0.94
0.73
4.2
4.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
56
1.61
0.72
1.0
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
97
842
1.16
0.70
1.1
1.2
—
—
—
0
0
(4212803)
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
26
1.93
0.70
1.2
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
115
1011
1.14
0.70
2.9
2.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
96
1102
0.87
0.70
1.2
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
41
1.71
0.70
1.3
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
41
509
0.80
0.69
1.5
1.6
e6/l
22686.7
15241.6
0.29
33
364
(21494434) Karyotype in Bone marrow
16
228
0.70
0.69
1.0
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
14
93
1.51
0.69
3.2
6.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
21
152
1.39
0.69
1.1
1.7
%
10.8
10.7
0.03
21
152
(3016650) Hepatitis A virus Ab [Presence] in Serum
32
248
1.29
0.69
1.0
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
27
1.85
0.68
3.8
4.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
79
677
1.17
0.68
1.3
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
48
584
0.82
0.68
1.1
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
106
1204
0.87
0.67
3.4
3.4
e9/l
5.2
4.2
2.18
84
860
(3013512) EKG study
595
6233
0.94
0.67
4.6
4.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
93
0.54
0.67
1.2
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
29
372
0.78
0.65
1.2
1.4
nmol/l
0.9
0.8
0.12
22
297
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
76
654
1.17
0.63
1.7
2.6
g/l
0.0
0.0
0.00
67
608
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
131
0.61
0.63
1.0
1.2
—
—
—
0
0
(4027681)
11
71
1.55
0.62
1.2
1.2
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
12
175
0.68
0.60
1.3
1.2
nmol/l
224.4
338.7
—
7
142
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
0
21
0.00
0.60
0.0
1.2
—
954.7
—
0
6
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
33
411
0.80
0.60
1.2
1.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1383
13547
1.05
0.58
4.9
4.2
mm/h
20.2
14.3
21.23
1308
12360
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
23
298
0.77
0.57
1.1
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
41
495
0.83
0.56
1.7
1.7
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
19
252
0.75
0.56
1.1
1.1
iu/ml
1.2
94.1
—
6
44
(44813793)
5
90
0.55
0.55
1.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
90
0.55
0.55
1.0
1.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
76
663
1.15
0.55
1.7
2.6
g/l
0.0
0.0
0.00
67
609
(3047181) Lactate [Moles/volume] in Blood
79
692
1.15
0.55
6.3
6.0
mmol/l
1.2
1.3
0.96
65
613
(1617658) Protocol used for examination of sentinel lymph nodes
8
123
0.65
0.54
1.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
8
125
0.64
0.54
2.6
1.7
—
—
—
0
0
(3020891) Body temperature
100
891
1.13
0.54
4.3
4.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
468
4465
1.06
0.53
1.3
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
14
193
0.72
0.53
1.0
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
56
479
1.17
0.53
1.6
1.5
g/l
1.1
1.2
1.46
50
458
(3006653) Thiamine [Moles/volume] in Blood
6
97
0.62
0.52
1.7
1.2
nmol/l
128.0
136.4
—
6
97
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
12
83
1.45
0.51
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
136
0.66
0.51
2.0
2.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
59
509
1.16
0.51
1.1
1.2
—
—
—
0
0
(3019977) pH of Arterial blood
18
135
1.34
0.51
2.9
2.7
ph
7.4
7.4
—
7
45
(3000330) Specific gravity of Urine by Test strip
98
1093
0.89
0.50
4.2
3.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
96
1072
0.89
0.50
1.8
1.9
g/l
1.5
1.5
0.06
88
963
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
30
367
0.82
0.49
1.2
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
159
1465
1.09
0.48
1.3
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
100
1108
0.90
0.47
2.4
2.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
18
137
1.32
0.47
2.7
3.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
59
515
1.15
0.45
1.1
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
241
0.79
0.43
1.1
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
39
331
1.18
0.43
1.2
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
59
518
1.14
0.43
1.1
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
17
218
0.78
0.42
1.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
94
0.64
0.42
2.7
4.0
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
18
140
1.29
0.42
1.1
1.2
g/l
3.0
2.8
—
9
100
(3025549) Creatine [Moles/time] in 24 hour Urine
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1284
12619
1.04
0.41
4.8
4.9
e6/l
295.4
2470.9
2.23
18
218
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
16
0.00
0.41
0.0
4.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.0
—
69.2
—
0
12
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
191
2036
0.93
0.40
1.3
1.3
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
18
0.00
0.40
0.0
4.7
—
—
—
0
0
(4211845)
7
102
0.69
0.39
6.0
3.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
105
0.67
0.39
1.0
1.4
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
27
323
0.83
0.38
1.1
1.2
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
13
98
1.33
0.37
1.0
1.1
u/l
35.8
33.7
0.05
13
68
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
13
98
1.33
0.37
1.0
1.1
u/l
116.8
87.9
0.32
13
70
(3017446) Testosterone [Moles/volume] in Serum or Plasma
140
1302
1.08
0.37
1.6
2.1
nmol/l
7.6
11.9
8.44
116
1111
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
113
0.71
0.37
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
24
198
1.21
0.36
1.3
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
135
0.74
0.36
1.1
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
161
1717
0.93
0.36
1.2
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
77
0.65
0.35
1.2
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
39
338
1.16
0.35
1.1
1.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
80
0.62
0.35
3.4
4.2
%
14.0
13.3
—
5
80
(3019420) Tryptase [Mass/volume] in Serum or Plasma
5
80
0.62
0.35
1.0
1.5
ug/l
5.7
11.0
—
5
72
(3051593) INR in Capillary blood by Coagulation assay
9
122
0.74
0.35
3.9
14.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
21
255
0.82
0.35
2.4
2.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
77
699
1.11
0.35
1.8
2.5
g/l
0.0
0.0
0.03
68
642
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
20
244
0.82
0.35
1.1
1.2
u/ml
222.9
299.1
1.00
12
139
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
12
91
1.32
0.33
1.7
3.5
u/l
202.2
216.5
0.40
12
91
(3025130) Human papilloma virus identified in Specimen
12
91
1.32
0.33
1.3
1.9
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1373
13916
0.97
0.33
39.5
21.0
%
14.5
13.9
33.26
1355
13557
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
31
361
0.86
0.33
1.3
1.4
e6/l
8.3
637.6
1.42
19
301
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
31
361
0.86
0.33
1.3
1.3
e6/l
5.0
36.4
1.21
19
289
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
100
1.30
0.33
1.2
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
17
210
0.81
0.33
1.0
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
27
228
1.19
0.33
1.3
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
6
46
1.31
0.33
18.2
16.7
nmol/l
1811.5
1485.5
—
6
46
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
6
87
0.69
0.33
1.5
1.7
nmol/l
12.2
15.9
—
6
77
(3051387) C reactive protein [Mass/volume] in Capillary blood
41
465
0.88
0.32
3.6
3.7
mg/l
36.5
28.8
0.41
27
291
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
37
323
1.15
0.31
1.2
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
151
1420
1.07
0.31
1.3
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
52
1.35
0.31
1.0
1.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
126
1346
0.93
0.31
2.1
2.8
g/l
9.9
10.8
1.81
115
1218
(3038515) Glucose [Moles/volume] in Venous blood
54
485
1.12
0.30
5.3
3.2
mmol/l
7.9
7.7
0.21
54
471
(3043410) Blood group antigens tested for on Red Blood Cells
7
54
1.30
0.30
1.1
2.2
—
—
—
0
0
(4268621)
16
129
1.24
0.30
2.3
2.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
55
1.27
0.30
1.3
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
199
2089
0.95
0.29
1.3
1.3
titre
617.9
533.2
0.23
47
477
(40757494) Bilirubin.total [Moles/volume] in Blood
8
111
0.72
0.28
3.4
1.9
—
29.8
—
0
9
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
234
2241
1.05
0.27
4.9
3.8
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
8
63
1.27
0.27
1.4
1.2
iu/ml
287.0
262.2
—
8
63
(3042111) Morphology [Interpretation] in Bone marrow Narrative
37
417
0.89
0.27
1.4
1.5
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
17
140
1.22
0.27
1.1
1.2
g/l
7.5
7.2
—
9
98
(3024139) IgG subclass 3 [Mass/volume] in Serum
17
140
1.22
0.27
1.1
1.2
g/l
0.5
0.4
—
9
99
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
117
0.77
0.27
2.2
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
117
0.77
0.27
2.2
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
86
1.28
0.26
1.0
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
73
0.68
0.26
1.4
1.7
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
5
73
0.68
0.26
1.2
1.2
—
39.5
—
0
34
(3006576) Bicarbonate [Moles/volume] in Blood
9
76
1.18
0.24
3.6
7.1
mmol/l
24.9
24.5
—
9
67
(3017704) Immunofixation for Urine
12
148
0.81
0.24
2.3
1.6
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
55
503
1.10
0.24
6.8
6.5
mmol/l
103.5
105.5
2.38
44
449
(3039000) Anion gap in Blood
55
503
1.10
0.24
6.8
6.5
mmol/l
11.0
11.2
0.19
44
449
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
137
0.80
0.24
1.1
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
78
1.28
0.24
1.1
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
29
255
1.14
0.24
1.2
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
69
744
0.93
0.23
2.7
2.9
g/l
0.7
0.3
1.67
28
291
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
41
453
0.90
0.23
1.2
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
11
136
0.81
0.23
3.6
2.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
52
566
0.92
0.22
1.1
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
90
846
1.07
0.22
1.2
1.3
u/ml
335.8
224.3
0.52
79
765
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
88
936
0.94
0.21
1.8
2.6
g/l
7.7
7.5
0.65
68
712
(3020618) Glucose [Moles/volume] in Synovial fluid
0
11
0.00
0.21
0.0
1.1
—
5.1
—
0
5
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
11
0.00
0.21
0.0
2.3
—
1.7
—
0
11
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.3
—
0.4
—
0
5
(3032868) Hemoglobin electrophoresis panel in Blood
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
88
935
0.94
0.21
1.8
2.6
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
12
0.00
0.21
0.0
3.3
—
—
—
0
0
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.4
—
20.4
—
0
7
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
23
262
0.88
0.21
1.1
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
98
1.23
0.21
1.2
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
(3024316) Viscosity of Plasma
0
13
0.00
0.21
0.0
1.5
—
1.7
—
0
7
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
88
934
0.94
0.20
1.8
2.6
g/l
3.8
3.8
0.06
67
687
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
118
1122
1.05
0.20
1.6
1.7
g/l
1.9
1.5
3.01
100
957
(3016018) Differential panel - Cerebral spinal fluid
19
164
1.16
0.20
1.2
1.3
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.4
—
32.3
—
0
7
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
0.2
—
0
5
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
53
573
0.92
0.20
1.7
1.6
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
48
1.25
0.20
1.5
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
33
298
1.11
0.19
1.1
1.3
—
—
—
0
0
(4281824)
16
186
0.86
0.19
1.1
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
35
384
0.91
0.18
1.5
1.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
53
570
0.93
0.18
1.3
1.5
ug/g
318.0
268.6
0.92
30
354
(3014051) Protein [Presence] in Urine by Test strip
42
456
0.92
0.18
1.9
2.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
61
1.15
0.17
1.3
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
61
1.15
0.17
1.1
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
78
737
1.06
0.17
1.7
2.5
g/l
36.8
37.1
0.20
68
638
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
16
184
0.87
0.17
1.7
1.9
mg/l
4.1
4.7
0.30
16
178
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
82
1.22
0.17
3.9
2.3
u/ml
781.2
1375.0
—
10
82
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
5
70
0.71
0.16
4.2
4.5
—
72.3
—
0
13
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
29
263
1.10
0.16
1.0
1.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
83
873
0.95
0.16
1.9
2.6
g/l
3.4
3.1
1.79
69
699
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
28
254
1.10
0.16
1.1
1.4
u/ml
194.1
112.1
—
8
42
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
98
1024
0.96
0.15
5.7
3.7
%
48.8
47.0
0.31
98
1011
(40768793) Breast Pathology biopsy report
37
342
1.08
0.15
1.2
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
27
246
1.10
0.14
1.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
27
246
1.10
0.14
1.4
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
63
664
0.95
0.13
1.1
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
63
598
1.06
0.13
3.0
3.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
198
2032
0.97
0.13
2.1
2.5
ug/l
3.6
7.4
8.20
175
1750
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
11
94
1.17
0.13
1.1
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
110
0.82
0.13
1.6
2.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
27
248
1.09
0.12
1.4
1.4
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
24
219
1.10
0.12
1.0
1.3
mu/l
108.1
59.3
0.38
19
188
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
168
0.89
0.11
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
35
327
1.07
0.11
1.2
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
12
136
0.88
0.11
1.0
1.1
u/ml
0.8
1.3
—
5
51
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
146
0.89
0.10
1.0
1.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
322
3171
1.02
0.10
26.1
28.9
inr
1.4
1.4
0.33
40
455
(3027944) Amphetamines [Presence] in Urine
12
106
1.13
0.09
1.1
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
16
176
0.91
0.09
1.1
1.3
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
11
97
1.13
0.09
1.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
25
233
1.07
0.09
1.2
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
32
339
0.94
0.08
1.3
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
56
1.07
0.08
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
12
107
1.12
0.08
1.0
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
64
0.78
0.08
1.2
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
87
896
0.97
0.08
1.3
1.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
82
796
1.03
0.08
2.6
3.6
mg/l
38.5
75.5
1.24
64
653
(3034860) Kappa light chains.free [Mass/volume] in Serum
82
796
1.03
0.08
2.6
3.6
mg/l
39.5
60.1
1.68
62
650
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
6
73
0.82
0.07
1.0
1.2
%
—
75.2
—
0
11
(3032773) Endomysium IgG Ab [Titer] in Serum
12
108
1.11
0.07
1.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
78
1.03
0.07
1.1
1.2
—
—
—
0
0
(44806420)
7
82
0.85
0.07
2.0
2.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
164
1611
1.02
0.07
3.9
4.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
11
122
0.90
0.07
3.5
2.5
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
87
1.03
0.07
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
87
1.03
0.07
1.0
1.0
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
96
937
1.03
0.07
6.0
4.8
%
1.7
1.6
0.35
84
878
(3020876) Protein [Mass/time] in 24 hour Urine
17
183
0.93
0.06
2.0
2.0
—
1.5
—
0
7
(3028300) Cannabinoids [Presence] in Urine
12
109
1.10
0.06
1.0
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
12
109
1.10
0.06
1.0
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
53
547
0.97
0.06
1.9
1.6
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
10
90
1.11
0.05
2.0
1.5
g/l
1.0
1.0
—
10
90
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
13
141
0.92
0.05
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
120
0.92
0.05
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
120
0.92
0.05
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
120
0.92
0.05
1.0
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
26
249
1.04
0.04
1.4
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
87
885
0.98
0.04
1.8
2.6
g/l
10.4
10.4
0.02
73
753
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
40
412
0.97
0.04
1.6
1.4
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
119
0.92
0.04
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
119
0.92
0.04
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
119
0.92
0.04
1.0
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
94
925
1.02
0.03
6.1
4.9
%
0.9
0.9
0.17
82
868
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
26
250
1.04
0.03
1.4
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
59
602
0.98
0.03
5.3
4.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
22
211
1.04
0.03
1.3
2.0
—
—
—
0
0
(4062490)
15
142
1.06
0.02
1.1
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
158
1592
0.99
0.02
2.6
3.9
ng/l
83.6
96.6
1.43
144
1357
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
13
137
0.95
0.01
1.0
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
81
801
1.01
0.01
1.8
2.7
g/l
0.9
1.3
0.55
66
690
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
17
177
0.96
0.01
1.0
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
19
183
1.04
0.01
1.7
2.3
ml
611.2
632.1
0.05
11
117
(3026008) Bacteria identified in Urine by Culture
631
6297
1.00
0.01
3.2
3.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
39
397
0.98
0.01
1.1
1.3
—
238.6
—
0
14
(3016879) Cocaine [Presence] in Urine
11
104
1.06
0.01
1.0
1.3
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
15
155
0.97
0.00
1.1
1.1
—
40.0
—
0
5
(3024980) IgG subclass 4 [Mass/volume] in Serum
24
235
1.02
0.00
1.1
1.6
g/l
0.7
0.9
0.79
14
179
(3047007) Chlamydophila sp Ab [Presence] in Serum
16
161
0.99
0.00
1.3
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
11
114
0.96
0.00
2.1
2.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
12
116
1.03
0.00
1.2
1.5
—
—
—
0
0
(1002224) Polysomnography panel
40
404
0.99
0.00
1.1
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
261
2612
1.00
0.00
1.3
1.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
29
287
1.01
0.00
1.7
2.4
u/ml
140.0
963.1
—
5
24
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
117
1.03
0.00
1.2
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
25
247
1.01
0.00
1.4
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
7
73
0.96
0.00
1.0
1.5
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
95
0.95
0.00
1.0
1.1
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
2.5
—
0
7
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
74
0.95
0.00
1.7
2.3
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
6
0.00
0.00
0.0
17.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
8
81
0.99
0.00
1.1
1.1
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
7
0.00
0.00
0.0
1.0
—
35.7
—
0
7
(3012989) Citrate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
1.9
—
0
5
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
6
0.00
0.00
0.0
5.0
—
385.3
—
0
6
(40760410) HLA-B [Type] by High resolution
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
83
0.96
0.00
1.0
1.1
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
7
0.00
0.00
0.0
1.1
—
7.6
—
0
7
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
1.1
—
0
6
(3018291) Platelet Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
9
96
0.94
0.00
1.0
1.8
—
10.0
—
0
5
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
6
0.00
0.00
0.0
6.8
—
67.0
—
0
6
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
7
70
1.00
0.00
1.0
1.1
ng/l
—
578.2
—
0
19
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
74
0.95
0.00
1.7
2.3
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_NSCLC_ADENO – Non-small cell lung cancer, adenocarcinoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).